TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
71,539
|
67,629
|
51,172 |
Financial expenses |
0
|
1
|
3 |
Earnings before taxes |
8,184
|
9,781
|
7,451 |
EBITDA |
7,415
|
9,103
|
4,995 |
Total assets |
31,997
|
30,673
|
21,736 |
Current assets |
26,758
|
27,483
|
18,239 |
Current liabilities |
7,483
|
10,507
|
6,533 |
Equity capital |
23,078
|
19,119
|
14,224 |
- share capital |
68
|
67
|
73 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
62.3%
|
65.4% |
Turnover per employee |
5,503
|
5,202
|
4,264 |
Profit as a percentage of turnover |
11.4%
|
14.5%
|
14.6% |
Return on assets (ROA) |
25.6%
|
31.9%
|
34.3% |
Current ratio |
357.6%
|
261.6%
|
279.2% |
Return on equity (ROE) |
35.5%
|
51.2%
|
52.4% |
Change turnover |
3,562
|
20,602
|
10,772 |
Change turnover % |
5%
|
44%
|
27% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.